Although its role in the context of metabolic diseases is still elusive, ANGPTL4 plasma levels have been reported to be significantly higher in patients with metabolic syndrome and were predictive for future cardiovascular events [26]. Here, ANGPTL4 is linked to metabolic syndrome.